SEC Form 4 · accession 0001179110-15-013947
CymaBay Therapeutics, Inc. · CBAY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert James Wills
Director
Period of report
Oct 6, 2015
Accepted (ET)
Oct 8, 2015 · 5:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001042074
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.04 | Oct 6, 2015 | A | 25,000 | A | — | Oct 5, 2025 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The option vests with respect to 25% of the underlying shares upon the first anniversary of the vesting commencement date of October 6, 2015, and then with respect to the remaining 75% of the underlying shares in 36 equal monthly installments.